Lung transplant study tests whether ECMO should be used routinely or only when needed
NCT ID NCT06615492
First seen Jun 27, 2026 · Last updated Jun 27, 2026
Summary
This study compares two ways of using a heart-lung support machine (ECMO) during lung transplants: using it routinely for all patients versus using it only when problems arise. About 218 adults with end-stage lung disease will take part. The goal is to see which approach leads to more days free from intensive care and fewer complications.
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
Active substance
Extracorporeal membrane oxygenation (ECMO) device
What this could lead to
If it works, this could show that using ECMO only when needed is safer and just as effective as using it routinely, potentially reducing complications like bleeding and infection.
What could go wrong
This is a single-center trial with 218 participants, so results may not apply to all hospitals. ECMO itself carries risks like bleeding and clotting, and the selective approach might not prevent severe complications in some patients.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for RESPIRATORY FAILURE are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
Centre Hospitalier de l'Universite de Montreal
RECRUITINGMontreal, Quebec, H2X3E4, Canada
Contact Phone: •••-•••-•••• Email: •••••@•••••
Contact Phone: •••-•••-•••• Email: •••••@•••••
Contact
-
Univeristy of Alberta & Alberta Health Services
NOT_YET_RECRUITINGEdmonton, Alberta, T6G2G3, Canada
Contact Phone: •••-•••-•••• Email: •••••@•••••
Contact
-
University Health Network / Toronto General Hospiatl
NOT_YET_RECRUITINGToronto, Ontario, M5G 1M1, Canada
Contact
Contact Phone: •••-•••-•••• Email: •••••@•••••
-
Vancouver General Hospital
NOT_YET_RECRUITINGVancouver, British Columbia, Canada
Contact Phone: •••-•••-•••• Email: •••••@•••••